Recall archive / FDA drug enforcement

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed... — FDA record D-0713-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jul 15, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Classification: Class III
Recalling firm: Asclemed USA Inc.
Quantity: 18 kits
Agency-reported status: Ongoing
Source record identifier: D-0713-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot: 070126X1, Exp. 12/31/2027.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Within U.S. - Tennessee

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Tennessee

Dates in the source

Report date: Jul 29, 2026
Recall initiation date: Jul 15, 2026
Center classification date: Jul 20, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.